Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases.
Ratings
1 / 5
1 rating in the last 12 months
5
4
3
2
1
CEO
Dr. Gene G. Kinney, PhD$1.1B
Market Cap • 25/04/20242012
(há 12 anos)
2012
(12 years ago)
NASDAQ
Listagem
Dublin 2
127
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
PRTASó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.